McDERMOTT AND EY AT THE
2022 J.P. MORGAN HEALTHCARE CONFERENCE
January 10-14, 2022
That’s a wrap on McDermott and EY at the 2022 J.P. Morgan Healthcare Conference! Thank you to all of our speakers and everyone who joined for the exclusive, virtual sessions with insights from industry leaders, innovators and investors from across the healthcare industry.

If you were unable to attend live, you can still register to view the sessions on-demand. And you can find all the program details below.

In the sessions, you’ll hear from healthcare leaders address the latest trends and implications across Digital Health, Life Sciences, Healthcare Private Equity (PE) and Hospitals and Health Systems (HHS). Use these insights to develop long-term, effective strategies for establishing deals and funding agreements to make a positive impact in 2022.

WHY ATTEND?

Prominent Speakers

Including executives from PE firms, investment banks, hospitals, health systems and other industry-leading organizations.

6 Substantive Programs

Exploring critical business and legal issues encountered by investors across the healthcare industry. Sessions will address emerging trends in Digital Health, Life Sciences, Healthcare Private Equity – including in Europe – Hospitals and Health Systems, and Health Technology Investing.

×

Content Here

×

Content Here

SCHEDULE

(All times in EST)

JANUARY 10, 2022

10:30 am – 12:45 pm 

LIFE SCIENCES INVESTMENT FORUM

Due to the rapid pace of change, life sciences companies are being forced to transform their business models, requiring greater focus on therapies or commercial models. Moving forward, companies will continue to use transactions as an important lever of transformation. This forum will address creative dealmaking strategies for growth in biopharma and medical technology as well as business model transformations companies should consider as they enter new deals.

JANUARY 11, 2022

11:00 am – 1:30 pm 

DIGITAL HEALTH PIONEERS FORUM

Advancements in digital health technology are driving greater innovation, with leaders looking to data and analytics as the future of patient care. Listen to executives from leading health technology companies for a series of fireside chats on the evolving models disrupting digital health, including the growing role that retail is playing in the space.

JANUARY 12, 2022

11:00 am – 2:00 pm 

HEALTHCARE PRIVATE EQUITY LEADERS FORUM

Leading private equity investors will explore key drivers and trends across diverse industry subsectors, examining how shifting regulations and the 2022 midterm elections may alter the deal landscape, and mapping out strategies for adapting and thriving amid change. The panelists will also offer their exclusive insights into emerging opportunities in health IT and will forecast the next evolution of today’s hyper-competitive market.

JANUARY 12, 2022

2:00 – 3:15 pm
ACCELERATION CAPITAL FORUM

Digital health has never been hotter and investor interest is surging across all stages. From early- to late-stage investments, lines are blurring with increased disruption in the digital health landscape. During this forum, PE and VC leaders will share their approaches to investing in 2022 and beyond.

JANUARY 13, 2022

11:00 am – 1:00 pm 

HOSPITALS & HEALTH SYSTEMS FORUM

Today’s hospitals and health systems face unprecedented levels of disruption. Hear from prominent health system executives as they share their perspectives on revenue growth strategies, novel partnerships and how the healthcare ecosystem is coming together more than ever before. These leaders will discuss developing trends and how to position your organization for growth to drive change in this fluid environment.

JANUARY 14, 2022

8:30 am – 9:30 am
EUROPEAN HEALTHCARE PRIVATE EQUITY FORUM
Private equity executives from across Europe will address a number of key issues and opportunities for investors heading into 2022. They’ll share their experiences entering the US market and why it’s such an important expansion piece of their portfolio; discuss the rise in transatlantic deals in the healthcare space; and address the role of global collaborations for life sciences companies.
Guest Faculty
Rick Abramson, MD, MHCDS, FACR
Chief Clinical Strategy Officer
Covera Health
Mert Aktar
Head of Corporate Development
Kite, a Gilead Company
Garo Armen, PhD
Chairman and Chief Executive Officer
Agenus
David Berman
Managing Partner
Lorient Capital
Marco Bonaiti
Vice President
Apax Partners
Preston Brice
Partner
Grant Avenue Capital

Dan Brillman
Chief Executive Officer & Co-Founder
Unite Us

Christopher Cleary
Vice President, Corporate Development
Medtronic

Peter Connolly
Managing Director, Head of North America
Cobepa
Owen Davis
Partner
Martis Capital
John DiGiovanni
Investment Partner
Arsenal Capital Partners
Deborah Di Sanzo
President
Best Buy Health

Mike Drazin
Chief Financial Officer
Medline

Henry Elphick
Deputy Chair, EHCPEA
Chair, Mansfield Advisors

Dr. Adaeze Enekwechi
Operating Partner
Welsh, Carson, Anderson & Stowe

Melanie Fan
Principal
Ampersand Capital Partners
Rushika Fernandopulle
Chief Innovation Officer
One Medical
Brian Fortune
Senior Managing Director
Farragut Square Group
Kendall Garrison
Partner
TPG Capital
Adam Grossman
Partner
Deerfield
Alyssa Jaffee
Partner
7wireVentures
Rohin Jain
Managing Director
H.I.G. Capital
John Kerins
Managing Director
Cain Brothers
Deborah Kilpatrick
Co-Chief Executive Officer & Executive Chair
Evidation
Barbara Krebs-Pohl
Chief Integration Officer and SVP, Head of Global BD&L and Alliance Management
MorphoSys

Tom Lee
Chief Executive Officer & Founder
Galileo

Geoff Lieberthal
Partner
Two Sigma Impact
David Mishkin
Senior Vice President
Valtruis, A WCAS Company
Jason Mulvihill
Chief Operating Officer and General Counsel
American Investment Council
John Nguyen
Chief Strategy Officer
SSM Health
Stephen Parodi, MD
Executive Vice President of External Affairs, Communications and Brand
The Permanente Federation
J.P. Peltier
Global Group Head, Healthcare Investment Banking
Piper Sandler

Dr. Michelle Perugini
Chief Executive Officer & Co-Founder
Presagen

Elizabeth Rockett
Managing Director
Kaiser Permanente Ventures
David Rhew, MD
Global Chief Medical Officer & VP of Healthcare
Microsoft
Sheri Shapiro
Senior Vice President and Chief Strategy Officer
Trinity Health
Rasu Shrestha, MD
Executive Vice President and Chief Strategy andTransformation Officer
Atrium
Glen Tullman
Chief Executive Officer, Transcarent
Founder & Managing Partner, 7wireVentures
Kristen Valdes
Founder and Chief Executive Officer
b.well Connected Health

Katherine Wood
Partner
TPG Capital

Asif Zaman
Partner
Public Pension Capital
Megan Zweig
Chief Operating Officer
Rock Health
McDermott Will & Emery
Stephen Bernstein
Co-Chair of Digital Health
McDermott Will & Emery
Jiayan Chen
Partner
McDermott Will & Emery
Ashley Fischer
Partner
McDermott Will & Emery
Brian Gordon
Partner
McDermott Will & Emery

SHARON LAMB
Partner
McDermott Will & Emery

Fred Levenson
Co-Head of Private Equity
McDermott Will & Emery
Lisa Mazur
Co-Chair of Digital Health
McDermott Will & Emery
Mara McDermott
Vice President
McDermott+ Consulting
Vernessa Pollard
Co-Chair of Life Sciences
McDermott Will & Emery

DR. STEPHAN RAU
Partner
McDermott Will & Emery

Jerry Sokol
Global Head of Health
McDermott Will & Emery
Dale Van Demark
Co-Chair of Digital Health
McDermott Will & Emery
Krist Werling
Co-Head of Private Equity
McDermott Will & Emery
EY
John Babitt
Partner, Life Sciences
Ernst & Young LLP
Subin Baral
Global Deals Leader, Life Sciences
Ernst & Young LLP
Slavena Bardarova
Principal
EY-Parthenon
H. Mallory Caldwell
US Health Leader
Ernst & Young LLP
tony drabble
Health & Life Sciences Sector Lead
EY-Parthenon U.K.
Nigel Gault
Chief Economist
EY-Parthenon
Rachel Hall
US Consulting Digital Health and Smart Health Experience Leader
Ernst & Young LLP
Jeff McMahon
Managing Director
Ernst & Young Capital Advisors, LLC
Heather Meade
Principal, Washington Council
Ernst & Young
Kenny O’Neill
Principal, Consulting, Digital Health
Ernst & Young LLP
Dan Shoenholz
Healthcare Private Equity Leader
EY-Parthenon
Adam Sorensen
US Health Integration and Divestiture Leader
EY-Parthenon
Arda Ural
Americas Industry Markets Leader, Health Sciences and Wellness
Ernst & Young LLP
Event Partner
McDermott and EY are proud to partner with the Healthcare Private Equity Association (HCPEA).

Contact
For questions, please contact our Events Team.

XING


Related Site:     McDermott+ Consulting

Attorney Advertising ©2021 McDermott Will & Emery